The Valley Desk

NCT02242643 · Interventional trial

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age

Overall registry status Completed

Phase 3

Conditions Influenza

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov